Dr. Anna Lembke, MD, is Assistant Professor at the department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is the Program Director for the Stanford Addiction Medicine Fellowship and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She completed a residency in Psychiatry, and a fellowship in mood disorders at the Stanford School of Medicine. She is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine. Dr. Lembke's key areas of interest include treating patients who have become addicted to prescription drugs, including research into patterns of physician opioid prescribing. She takes a holistic, harm-reduction approach to each patient, and encourages spiritual and alternative therapies in the process of healing. Dr. Lembke has developed multiple teaching programs on drug misuse and addiction therapy. She has held multiple leadership and mentorship positions and has received Stanford’s Chairman’s Award for Clinical Innovation. She has chaired the Planning Committee for the California Society of Addiction Medicine (CSAM) Annual Addiction Medicine Conference. She is the president of the Addiction Medicine Fellowship Directors Association (AMFDA). She has published over 50 peer-reviewed articles, chapters, and commentaries, including in the New England Journal of Medicine, the Journal of the American Medical Association, the Journal of General Internal Medicine, American Family Physician, and Addiction. She is the author of a new book on the prescription drug epidemic: Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop (Johns Hopkins University Press, November 2016).